Related Experiment Video
Updated: Nov 3, 2025

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
Published on: May 26, 2015
Flecainide-Induced Atrial Flutter With 1:1 Conduction Complicated by Ventricular Fibrillation After Electrical
Timothy Colangelo1, Drew Johnson2, Reginald Ho2
1Department of Internal Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania.
Flecainide can rarely cause rapid atrial flutter, leading to ventricular fibrillation. This case highlights the proarrhythmic risks of flecainide and the need for careful patient management.
Area of Science:
- Cardiology
- Electrophysiology
- Pharmacology
Background:
- Flecainide is a Class IC antiarrhythmic drug commonly used for atrial arrhythmias.
- Atrial fibrillation management can involve flecainide maintenance therapy.
Observation:
- A 59-year-old male on flecainide for refractory atrial fibrillation developed 1:1 atrial flutter with rapid conduction.
- Synchronized cardioversion attempt by emergency medical technicians resulted in ventricular fibrillation, requiring defibrillation.
Findings:
- Flecainide can induce atrial proarrhythmic effects, including 1:1 atrial flutter.
- Rapid ventricular response during atrial flutter can precipitate life-threatening arrhythmias like ventricular fibrillation.
Implications:
- This case underscores the importance of recognizing and managing flecainide-induced proarrhythmias.
- Radiofrequency ablation and cryoablation were effective in resolving symptomatic atrial flutter in this high-risk patient.
- Mitigation strategies are crucial for high-risk patients on flecainide to prevent adverse cardiac events.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias III: Characteristics of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...

